☆ 4.0 Letter

CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al

ARTHRITIS AND RHEUMATISM (2013)

Journal

ARTHRITIS AND RHEUMATISM

Volume 65, Issue 4, Pages 1130-1131

Publisher

WILEY-BLACKWELL

DOI: 10.1002/art.37871

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.